Advancing Research

MAPS spent decades developing MDMA-assisted therapy as a means to Set the Setting for the clinical utilization of psychedelic-assisted therapies. With the road paved for the next generation of research and drug development, MAPS now stewards the research landscape we helped cultivate.

We are dedicated to fostering new research directions that Prioritize Public Benefit, supporting international researchers and pilot programs, and ensuring the accessibility and culturally appropriate integration of psychedelics as a tool for individual and community wellness. We practice Open Science, Open Books, and center research that contributes to knowledge in the public domain.

Click the button below to learn more about current MAPS research initiatives.

Tenets of Research Stewardship 

We fill gaps in the ecosystem to Prioritize Public Benefit, rather than profit

We accelerate new research to inform public knowledge and sensible policy reform

We maximize access domestically and globally to work toward Healing for All

We Accelerate Psychedelic Research

MAPS is proud to fund and support researchers worldwide to advance our collective understanding of the potential applications and risks associated with psychedelics. We award grants and provide fiscal sponsorship, by invitation only, to independent research projects aligned with MAPS’ mission.

Click here to learn more about our Fiscal Sponsorship program.
MAPS initiates projects that open new research directions or set regulatory precedents. We strive to lay the groundwork for new or challenging research fields by fostering studies that expand our collective knowledge of the possible uses and delivery of psychedelics.
MAPS provides international therapist education programs to equip care providers with the fundamentals and best practices of psychedelic-assisted therapies to increase awareness and activate potential research initiatives across the globe.

Click here for more information on our International Therapist Education Program.
MAPS is building the capacity to expand our regulatory, protocol, and diversity consultation services to select independently funded researchers and MAPS grantees.

Browse by substance

MDMA

MDMA-assisted therapy can help heal psychological disorders and trauma. Learn about our studies and find resources like our Investigator’s Brochure and treatment manual.

LEARN MORE

Cannabis

Cannabis treatment shows progress for symptoms of PTSD in war veterans.

LEARN MORE

LSD

A pilot study of LSD-assisted therapy demonstrated a reduction in anxiety among people with a life-threatening illness.

LEARN MORE

Ibogaine

New Zealand and Mexico studies show ibogaine can help opioid and alcohol addiction.

LEARN MORE

Ayahuasca

Our study suggested ayahuasca-assisted therapy may be useful for treating drug addiction.

LEARN MORE

Latest News

See what’s happening in today’s psychedelic science news.

MAPS, MDMA & Beyond Webinar

July 12, 2024
Join MAPS leaders Kris Lotlikar, Ismail Ali, J.D., Allison Coker, Ph.D., and Betty Aldworth to delve into the approaches and strategies MAPS is engaging during this critical juncture. After 38 years of …
Read more
See more

Want to
get involved?

Learn about the many ways to join the psychedelic community, from membership, volunteering, and careers to learning how to get involved with psychedelic-assisted therapy.

Take Action
group of people